Abstract

IntroductionMigraine has long been known as a common complex disease caused by genetic and environmental factors. The pathophysiology and the specific genetic susceptibility are poorly understood. Common variants only explain a small part of the heritability of migraine. It is thought that rare genetic variants with bigger effect size may be involved in the disease. Since migraine has a tendency to cluster in families, a family approach might be the way to find these variants. This is also indicated by identification of migraine-associated loci in classical linkage-analyses in migraine families. A single migraine study using a candidate-gene approach was performed in 2010 identifying a rare mutation in the TRESK potassium channel segregating in a large family with migraine with aura, but this finding has later become questioned. The technologies of next-generation sequencing (NGS) now provides an affordable tool to investigate the genetic variation in the entire exome or genome. The family-based study design using NGS is described in this paper. We also review family studies using NGS that have been successful in finding rare variants in other common complex diseases in order to argue the promising application of a family approach to migraine.MethodPubMed was searched to find studies that looked for rare genetic variants in common complex diseases through a family-based design using NGS, excluding studies looking for de-novo mutations, or using a candidate-gene approach and studies on cancer. All issues from Nature Genetics and PLOS genetics 2014, 2015 and 2016 (UTAI June) were screened for relevant papers. Reference lists from included and other relevant papers were also searched. For the description of the family-based study design using NGS an in-house protocol was used.ResultsThirty-two successful studies, which covered 16 different common complex diseases, were included in this paper. We also found a single migraine study. Twenty-three studies found one or a few family specific variants (less than five), while other studies found several possible variants. Not all of them were genome wide significant. Four studies performed follow-up analyses in unrelated cases and controls and calculated odds ratios that supported an association between detected variants and risk of disease. Studies of 11 diseases identified rare variants that segregated fully or to a large degree with the disease in the pedigrees.ConclusionIt is possible to find rare high risk variants for common complex diseases through a family-based approach. One study using a family approach and NGS to find rare variants in migraine has already been published but with strong limitations. More studies are under way.

Highlights

  • Migraine has long been known as a common complex disease caused by genetic and environmental factors

  • PubMed was searched to find studies that looked for rare genetic variants in common complex diseases through a family-based design using next-generation sequencing (NGS), excluding studies looking for de-novo mutations, or using a candidate-gene approach and studies on cancer

  • We found a single migraine study

Read more

Summary

Introduction

Migraine has long been known as a common complex disease caused by genetic and environmental factors. Since migraine has a tendency to cluster in families, a family approach might be the way to find these variants. We review family studies using NGS that have been successful in finding rare variants in other common complex diseases in order to argue the promising application of a family approach to migraine. With a lifetime prevalence of 16%, migraine affects 75 million Europeans It can be very disabling for the individual and is a large economic burden to society [1]. A higher concordance of migraine in monozygotic than in dizygotic twins, and the 1.9-3.8 fold higher risk of migraine among first degree relatives of affected individuals, indicates an important genetic component [2,3,4,5] Twin studies show a heritability of 34%– 65% [5, 6]. The diagnosis of migraine is based solely on patients’ history in the absence of validated biomarkers

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call